Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape.
Jiang X, Wang J, Deng X, Xiong F, Ge J, Xiang B, Wu X, Ma J, Zhou M, Li X, Li Y, Li G, Xiong W, Guo C, Zeng Z. · 2019
Read Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape. by Jiang X, Wang J, Deng X, Xiong F, Ge J, Xiang B, Wu X, Ma J, Zhou M, Li X, Li Y, Li G, Xiong W, Guo C, Zeng Z. (2019) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6332843.txt.
Description
Jiang and co-authors review how tumors use the PD-1 pathway to escape immunity. Their review appeared in Molecular Cancer. PD-1 is a brake on T cells, the immune attackers. Its partner, PD-L1, sits on tumor and nearby cells. When they engage, T cell attack is blunted. Drugs blocking this pair have changed cancer care.
Yet many patients gain little from those drugs. The review explains why responses stay weak. It maps what drives PD-L1 levels in the tumor setting. Signals from immune cells, genes, and stress all play in. The surrounding tissue shapes the pathway at every step. Understanding that web may sharpen drug use. It may also suggest pairs of drugs that work better together.
Catalog record
| CREATOR | Jiang X, Wang J, Deng X, Xiong F, Ge J, Xiang B, Wu X, Ma J, Zhou M, Li X, Li Y, Li G, Xiong W, Guo C, Zeng Z. |
|---|---|
| YEAR | 2019 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 91 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |